Regencell Bioscience Holdings Limited RGC
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.36M | 2.36M | 4.90M | 4.90M | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 5.80K | 5.80K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 6.59M |
| Total Current Assets | 2.36M | 2.36M | 4.90M | 4.90M | 6.59M |
|
|
|||||
| Total Current Assets | 2.36M | 2.36M | 4.90M | 4.90M | 6.59M |
| Net Property, Plant & Equipment | 562.70K | 562.70K | 759.80K | 759.80K | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 93.40K | 93.40K | 93.00K | 93.00K | 892.70K |
| Total Assets | 3.01M | 3.01M | 5.76M | 5.76M | 7.48M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 1.41M | 1.41M | 348.40K | 348.40K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 258.10K | 258.10K | 312.80K | 312.80K | -- |
| Total Finance Division Other Current Liabilities | 100.00 | 100.00 | 2.50K | 2.50K | -- |
| Total Other Current Liabilities | 100.00 | 100.00 | 2.50K | 2.50K | -- |
| Total Current Liabilities | 1.67M | 1.67M | 663.70K | 663.70K | -- |
|
|
|||||
| Total Current Liabilities | 1.67M | 1.67M | 663.70K | 663.70K | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 128.20K | 128.20K | 231.60K | 231.60K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 763.80K |
| Total Liabilities | 1.79M | 1.79M | 895.30K | 895.30K | 763.80K |
|
|
|||||
| Common Stock & APIC | 31.76M | 31.76M | 30.13M | 30.13M | 6.72M |
| Retained Earnings | -30.52M | -30.52M | -25.20M | -25.20M | -- |
| Treasury Stock & Other | -24.70K | -24.70K | -64.80K | -64.80K | -- |
| Total Common Equity | 1.22M | 1.22M | 4.86M | 4.86M | 6.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.22M | 1.22M | 4.86M | 4.86M | 6.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.22M | 1.22M | 4.86M | 4.86M | 6.72M |
|
|
|||||